GLP-1 Constipation: Causes and Remedies

GLP-1 medications can cause constipation because they slow digestion and often change how much you eat, drink, and move from day to day. It is usually most noticeable early in treatment or after dose increases, and many people improve with hydration, meal structure, movement, and time.

Why Do GLP-1 Medications Cause Constipation?

GLP-1 receptor agonists work by mimicking a natural gut hormone called glucagon-like peptide-1. One of their key therapeutic effects is slowing gastric emptying — the speed at which food moves from the stomach into the small intestine. This helps control blood sugar and reduces appetite, but it also slows the entire digestive tract. For a more detailed explanation, see our guide on how GLP-1 medications work.

Specifically, GLP-1 receptor activation relaxes the stomach muscles, inhibits movement (motility) in the lower stomach and upper small intestine, and increases pressure in the pyloric sphincter — the valve connecting the stomach to the intestine. A case series published in the American Journal of Gastroenterology found that delayed gastric emptying was observed in 80% of patients taking GLP-1 receptor agonists, with semaglutide users showing the longest transit times.

When food moves more slowly through the intestines, more water is absorbed from the stool, making it harder and more difficult to pass. This is the primary mechanism behind GLP-1 related constipation.

How Common Is Constipation on Different GLP-1 Medications?

Constipation rates vary by medication, dose, and whether the drug is prescribed for type 2 diabetes or weight management. Higher doses used for weight loss tend to produce higher rates. The table below summarizes data from major clinical trials and FDA prescribing information.

A Bayesian network meta-analysis of 48 randomized controlled trials involving 27,729 participants found that semaglutide carried the highest risk of constipation among GLP-1 receptor agonists, while shorter-acting agents like exenatide had the lowest risk.

When Does Constipation Typically Start and How Long Does It Last?

Constipation most commonly develops within the first 4–8 weeks of treatment, during or shortly after dose escalation. A pooled analysis of the STEP trial program found that the prevalence of constipation plateaued at approximately week 10 and that most cases were non-serious (99.5%) and mild to moderate in severity (98.1%).

The median duration of constipation was approximately 47 days in semaglutide-treated patients compared to 35 days in the placebo group, based on STEP trial data. This means constipation tends to last longer than other gastrointestinal side effects like nausea, but it does improve for most people as their body adjusts. If you are also experiencing nausea on your GLP-1 medication, these side effects often share a similar timeline tied to dose increases.

What Are the Best Remedies for GLP-1 Constipation?

Several evidence-based strategies can help relieve constipation while taking GLP-1 medications. Most people find relief by combining two or three of these approaches.

Increase water intake

Healthcare providers generally recommend drinking at least 64 ounces (about 8 cups) of water per day, though some patients on GLP-1 medications may benefit from 80–100 ounces daily. When the digestive tract is moving slowly, adequate hydration helps keep stool soft and easier to pass. Because GLP-1 medications can also reduce thirst signals alongside appetite, it is important to drink water consistently throughout the day even when not feeling thirsty.

Add soluble fiber gradually

Aim for 25–35 grams of soluble fiber per day from sources like oats, beans, apples, ground flaxseeds, and chia seeds. Soluble fiber absorbs water in the gut and forms a gel that softens stool. Psyllium husk (found in products like Metamucil) is a well-studied bulk-forming agent that can be particularly helpful.

One important caution: increase fiber intake gradually over 1–2 weeks. Adding too much fiber too quickly can worsen bloating and gas, especially when your digestive system is already slowed by a GLP-1 medication.

Walk after meals

Walking for just 10–15 minutes after meals stimulates the gastrocolic reflex — a natural signal that prompts the colon to contract after eating. Regular physical activity has been shown to improve bowel motility in general, and it can help counteract the slowed transit caused by GLP-1 receptor activation. Even light movement like a short stroll makes a difference.

Try natural bowel-friendly foods

Certain foods have mild natural laxative effects and may help keep things moving. Prunes or prune juice contain sorbitol, a sugar alcohol that draws water into the intestines. Kiwifruit (1–2 per day) has been shown in clinical studies to improve stool consistency and frequency. Ground flaxseeds (1–2 tablespoons daily mixed into yogurt or smoothies) add both fiber and healthy fats that can support regularity.

Consider over-the-counter options

If dietary changes alone are not enough, talk to your healthcare provider about over-the-counter laxatives. There are three main categories:

• Bulk-forming agents such as psyllium (Metamucil) and methylcellulose (Citrucel) trap water in the intestine and soften stool. These are generally the first-line recommendation and are safe for long-term use.
• Osmotic laxatives such as polyethylene glycol (MiraLAX), magnesium citrate, and lactulose draw water into the colon to soften stool and improve transit. Magnesium-based products should be used with caution in people with kidney problems.
• Stimulant laxatives such as bisacodyl (Dulcolax) and senna stimulate intestinal muscles to push stool forward. These are typically used short-term when other approaches have not worked, as long-term use can lead to dependence.

Should You Be Concerned About Constipation on GLP-1 Medications?

For most patients, GLP-1 related constipation is manageable and not dangerous. Only about 4.3% of participants in the STEP trial program permanently discontinued treatment due to any gastrointestinal adverse event, and constipation alone was rarely a reason for stopping.

However, you should contact your healthcare provider if you experience any of the following: no bowel movement for 3 or more days, severe abdominal pain or bloating, blood in your stool, vomiting along with constipation, or if over-the-counter remedies are not providing relief after 1–2 weeks. In rare cases, severe constipation can lead to fecal impaction or intestinal obstruction, which requires medical attention.

Does Constipation Affect Weight Loss on GLP-1 Medications?

The pooled analysis of the STEP trial program found no meaningful difference in weight loss between patients who experienced gastrointestinal side effects and those who did not. In other words, constipation does not appear to reduce the effectiveness of GLP-1 medications for weight management.

That said, constipation can cause temporary fluctuations on the scale. If you notice a small increase in weight or a plateau that coincides with constipation, it may reflect retained stool rather than actual fat gain. Tracking your symptoms alongside your weight in an app like Glone can help you see patterns and avoid unnecessary concern about short-term number changes.

Can You Prevent Constipation Before It Starts?

Taking proactive steps from the very first week of treatment can reduce the likelihood and severity of constipation. Start increasing your water intake before you begin your GLP-1 medication. Add high-fiber foods to your diet gradually. Establish a daily walking routine, even if it is just 10 minutes after your main meal.

Following the recommended dose-escalation schedule is also important. Dose titration — for example, starting Ozempic at 0.25 mg and increasing to 0.5 mg after 4 weeks — gives your digestive system time to adjust. Skipping doses or increasing too quickly can worsen all gastrointestinal side effects, including constipation. You can learn more about proper titration in our Ozempic side effects week-by-week guide.

Glone's symptom tracking feature lets you log constipation alongside your injection dates and doses, making it easier to spot whether constipation corresponds to dose changes — information you can share with your healthcare provider at your next visit.

Sources

• FDA Prescribing Information for Ozempic (semaglutide) — accessdata.fda.gov
• Gastrointestinal tolerability of once-weekly semaglutide 2.4 mg (STEP trials pooled analysis) — pmc.ncbi.nlm.nih.gov
• Comparative gastrointestinal adverse effects of GLP-1 receptor agonists (Bayesian network meta-analysis) — pmc.ncbi.nlm.nih.gov
• Impact of GLP-1 Receptor Agonists on Whole-Gut Gastrointestinal Motility (case series) — pmc.ncbi.nlm.nih.gov
• FDA Prescribing Information for Mounjaro (tirzepatide) — accessdata.fda.gov
• SURMOUNT-1 results (tirzepatide for obesity) — investor.lilly.com